These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Intraindividual Comparison of Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569 [TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
9. Combined model-based and patient-specific dosimetry for Plyku D; Mena E; Rowe SP; Lodge MA; Szabo Z; Cho SY; Pomper MG; Sgouros G; Hobbs RF Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):989-998. PubMed ID: 29460025 [TBL] [Abstract][Full Text] [Related]
10. Repeatability of Quantitative Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729 [TBL] [Abstract][Full Text] [Related]
11. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223 [TBL] [Abstract][Full Text] [Related]
12. The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study. Harsini S; Saprunoff H; Alden T; Mohammadi B; Wilson D; Bénard F J Nucl Med; 2021 Jan; 62(1):81-87. PubMed ID: 32385167 [TBL] [Abstract][Full Text] [Related]
13. Lack of repeatability of radiomic features derived from PET scans: Results from a Werner RA; Habacha B; Lütje S; Bundschuh L; Kosmala A; Essler M; Derlin T; Higuchi T; Lapa C; Buck AK; Pienta KJ; Lodge MA; Eisenberger MA; Markowski MC; Pomper MG; Gorin MA; Frey EC; Rowe SP; Bundschuh RA Prostate; 2023 May; 83(6):547-554. PubMed ID: 36632656 [TBL] [Abstract][Full Text] [Related]
14. Prospective intraindividual comparison of 18F-PSMA-7Q and 18F-DCFPyL PET/CT in patients with newly diagnosed prostate cancer. Liu Y; Zhang X; Liu J; Zhang J; Xu B Nucl Med Commun; 2022 Jun; 43(6):725-730. PubMed ID: 35560134 [TBL] [Abstract][Full Text] [Related]
15. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer. Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322 [TBL] [Abstract][Full Text] [Related]
16. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer. Dietlein M; Kobe C; Kuhnert G; Stockter S; Fischer T; Schomäcker K; Schmidt M; Dietlein F; Zlatopolskiy BD; Krapf P; Richarz R; Neubauer S; Drzezga A; Neumaier B Mol Imaging Biol; 2015 Aug; 17(4):575-84. PubMed ID: 26013479 [TBL] [Abstract][Full Text] [Related]
17. Prospective Comparison of PET Imaging with PSMA-Targeted Rowe SP; Li X; Trock BJ; Werner RA; Frey S; DiGianvittorio M; Bleiler JK; Reyes DK; Abdallah R; Pienta KJ; Gorin MA; Pomper MG J Nucl Med; 2020 Feb; 61(2):183-188. PubMed ID: 31451492 [TBL] [Abstract][Full Text] [Related]
18. Prospective Evaluation of Gaur S; Mena E; Harmon SA; Lindenberg ML; Adler S; Ton AT; Shih JH; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Mease RC; Pomper MG; Choyke PL; Turkbey B AJR Am J Roentgenol; 2020 Sep; 215(3):652-659. PubMed ID: 32755168 [No Abstract] [Full Text] [Related]